Advertisement
The author of the article, Dr. Robert Kirsner, MD, PhD, and a pastpresident of the Association for the Advancement of Wound Care, states, "Aspecific honey, the so-called Manuka honey predominantly sourced from theLeptospermum species from New Zealand and Australia, has been found to haveother properties that may render it superior to other honeys. Specifically,this honey appears to have superior and broad-spectrum antimicrobialproperties." He went on to say that the first Leptospermum honey-basedproduct to enter into the market, MEDIHONEY, is likely to draw significantinterest from a public desirous of natural products, and that well-donestudies such as the George/Cutting study will help to garner interest bymedical professionals.
Advertisement
Derma Sciences CEO Ed Quilty stated, "We are fully aware that, althoughthe benefits of MEDIHONEY have captured the imagination of the public and themedical community alike, it is only through well-designed studies and rigorousclinical evaluations with positive outcomes that widespread adoption and usageof MEDIHONEY will occur. We are glad to see the recognition of theGeorge/Cutting study, and look forward to additional studies on MEDIHONEYbeing published later this year. Additionally, we continue to receive astream of positive clinical evaluations from many wound centers around theglobe."
Quilty added, "Our next big milestone is the World Union of Wound HealingSocieties conference in Toronto during the first week in June. Thisconference takes place only once every four years and it draws doctorsinterested in wound care from all over the globe."
Both these points are notable with comparison to the recent GeorginaGethin study presented last Spring at the European Wound ManagementAssociation. This 108-patient randomized controlled study showed that 44% ofthe non-healing venous leg ulcers treated with Active Leptospermum Honey undercompression devices healed within the 12-week study duration, in addition tolowering the incidence of infection. This underscores the wound healingbenefit of the dressing in addition to its antimicrobial capability, a featureatypical within common antimicrobial dressings. The study also showed thatthe dressing was associated with improved autolytic debridement (a morenatural and less invasive form of debridement than surgical/mechanicaldebridement).
(Information in this article concerns a use that has not been cleared bythe US Food and Drug Administration.)
About Skin & Aging
Skin & Aging provides practical and clinical insight into today's generaldermatology issues. This award-winning publication offers dermatologistsreader-friendly, timely and informative articles that highlight clinical andpractice management advice that easily can be translated into current practicesettings.
About Derma Sciences
Derma Sciences is a global manufacturer and marketer of advanced woundcare products. Its key product, MEDIHONEY, is sold throughout the world byDerma Sciences and Comvita New Zealand -- the licensor of the patentedhoney-based technology -- and is the leading brand of honey-based dressingsfor the management of wounds and burns. The product has been shown to beeffective in a variety of wounds and burns, and was recently the focus of twopositive large-scale rando
